TotalMarketCap

Capricor Therapeutics

CAPRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$499.414 M

$8.59 -3.70%

Close of 6 Nov 2026

As of 6 Nov 2026, Capricor Therapeutics (CAPR) has a market capitalization of $499.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$105.0M

Loss-making

Shares outstanding

58,138,989

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #187Puma BiotechnologyPBYI$505.4M
  2. #188Ovid TherapeuticsOVID$503.9M
  3. #189Capricor TherapeuticsCAPR$499.4M
  4. #190DiaMedica TherapeuticsDMAC$488.6M
  5. #191Indaptus TherapeuticsINDP$483.8M

What if Capricor Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$485,678.79

Per share 56,540× higher

Bitcoin $1.53T

$26,279.23

Per share 3,059× higher

Apple $5.02T

$86,272.27

Per share 10,043× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Capricor Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.